말단비대증 치료 시장 규모, 점유율, 성장 분석 : 질환 유형별, 진단 유형별, 치료 유형별, 지역별 - 업계 예측(2026-2033년)

Global Acromegaly Treatment Market size was valued at USD 1.49 Billion in 2024 and is poised to grow from USD 1.58 Billion in 2025 to USD 2.54 Billion by 2033, growing at a CAGR of 6.1% during the forecast period (2026-2033).

The acromegaly treatment market is experiencing robust growth driven by an increasing incidence of the disease and a demand for innovative therapies. Pharmaceutical companies are heavily investing in research and development to create new drug formulations and delivery methods. The rise in hereditary and lifestyle-related hormonal disorders, such as hypopituitarism, further fuels market expansion. Advancements in technology and supportive government initiatives present substantial opportunities for market players. A strong pharmacological pipeline, featuring multiple anticipated approvals for growth hormone receptor antagonists and somatostatin analogues, is set to enhance the treatment landscape. Additionally, government policies and insurance coverage for rare diseases, particularly in regions like the U.S., Europe, and Japan, will contribute significantly to the market's future growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Acromegaly Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Acromegaly Treatment Market Segments Analysis

Global Acromegaly Treatment Market is segmented by Disease Type, Diagnosis Type, Treatment Type and region. Based on Disease Type, the market is segmented into Ectopic Acromegaly and Pseudo Acromegaly. Based on Diagnosis Type, the market is segmented into Medical Imaging and Medical Laboratory Test. Based on Treatment Type, the market is segmented into Surgery, Drug Therapy and Radiation Therapy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Acromegaly Treatment Market

The rising incidence of acromegaly, a rare hormonal disorder resulting from elevated growth hormone levels, significantly propels the acromegaly treatment market. As understanding and recognition of this condition expand, more individuals are being diagnosed, resulting in an escalating demand for effective treatment solutions. This heightened awareness among healthcare providers and patients alike contributes to the market's growth, as the need for innovative therapies and interventions becomes increasingly vital to manage this complex disorder. Consequently, the emphasis on improved treatment outcomes for those affected further stimulates market expansion and investment in research and development.

Restraints in the Global Acromegaly Treatment Market

The Global Acromegaly Treatment market faces significant challenges due to the condition's tendency to remain undiagnosed or to be diagnosed later in its progression, largely because of its gradual onset and ambiguous symptoms. This issue is compounded by a lack of awareness among both healthcare practitioners and the general public regarding acromegaly, which inhibits early detection and the swift commencement of treatment. Such factors collectively serve as a restraint to the growth of the market, as timely intervention is crucial for better patient outcomes and an effective treatment pathway.

Market Trends of the Global Acromegaly Treatment Market

The Global Acromegaly Treatment market is increasingly characterized by a rise in targeted therapeutic approaches, particularly through the use of somatostatin analogs and growth hormone receptor antagonists. This evolving trend underscores a significant shift from conventional treatment methods to more precise solutions that directly address the hormonal imbalances associated with acromegaly. These targeted therapies not only enhance treatment efficacy but also improve patient tolerability, thus fostering a more favorable patient experience. As healthcare providers seek to optimize outcomes and minimize side effects, the demand for innovative treatments within this market is expected to grow, reflecting a broader movement towards personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Acromegaly Treatment Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Ectopic Acromegaly
• Pseudo Acromegaly

Global Acromegaly Treatment Market Size by Diagnosis Type & CAGR (2026-2033)

• Market Overview
• Medical Imaging
• Medical Laboratory Test

Global Acromegaly Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Surgery
• Drug Therapy
• Radiation Therapy

Global Acromegaly Treatment Market Size & CAGR (2026-2033)

• North America (Disease Type, Diagnosis Type, Treatment Type)
  • US
  • Canada
• Europe (Disease Type, Diagnosis Type, Treatment Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Type, Diagnosis Type, Treatment Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Type, Diagnosis Type, Treatment Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Type, Diagnosis Type, Treatment Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crinetics Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strongbridge Biopharma plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ionis Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recordati S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xeris Biopharma Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peptron Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations